INSPIREMD 1/18 DL-0001 (II2) - Total Assets
Based on the latest financial reports, INSPIREMD 1/18 DL-0001 (II2) holds total assets worth €69.40 Million EUR (≈ $81.14 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore INSPIREMD 1/18 DL-0001 cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
INSPIREMD 1/18 DL-0001 - Total Assets Trend (2021–2025)
This chart illustrates how INSPIREMD 1/18 DL-0001's total assets have evolved over time, based on quarterly financial data. See II2 book value for net asset value and shareholders' equity analysis.
INSPIREMD 1/18 DL-0001 - Asset Composition Analysis
Current Asset Composition (December 2025)
INSPIREMD 1/18 DL-0001's total assets of €69.40 Million consist of 88.6% current assets and 11.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 12.9% |
| Accounts Receivable | €2.17 Million | 3.1% |
| Inventory | €3.40 Million | 4.9% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how INSPIREMD 1/18 DL-0001's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see INSPIREMD 1/18 DL-0001 (II2) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: INSPIREMD 1/18 DL-0001's current assets represent 88.6% of total assets in 2025, a decrease from 93.4% in 2021.
- Cash Position: Cash and equivalents constituted 12.9% of total assets in 2025, down from 30.2% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 4.9% of total assets.
INSPIREMD 1/18 DL-0001 Competitors by Total Assets
Key competitors of INSPIREMD 1/18 DL-0001 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
GN Store Nord
CO:GN
|
Denmark | Dkr29.23 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Beijing Succeeder Technology Inc
SHG:688338
|
China | CN¥1.78 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.02 Billion |
|
Stratec SE
XETRA:SBS
|
Germany | €443.38 Million |
INSPIREMD 1/18 DL-0001 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.74 | 5.28 | 6.39 |
| Quick Ratio | 5.42 | 4.94 | 6.05 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €50.76 Million | €32.84 Million | €39.13 Million |
INSPIREMD 1/18 DL-0001 - Advanced Valuation Insights
This section examines the relationship between INSPIREMD 1/18 DL-0001's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.15 |
| Latest Market Cap to Assets Ratio | 0.40 |
| Asset Growth Rate (YoY) | 48.3% |
| Total Assets | €69.40 Million |
| Market Capitalization | $27.96 Million USD |
Valuation Analysis
Below Book Valuation: The market values INSPIREMD 1/18 DL-0001's assets below their book value (0.40x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: INSPIREMD 1/18 DL-0001's assets grew by 48.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for INSPIREMD 1/18 DL-0001 (2021–2025)
The table below shows the annual total assets of INSPIREMD 1/18 DL-0001 from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €69.40 Million ≈ $81.14 Million |
+48.28% |
| 2024-12-31 | €46.81 Million ≈ $54.72 Million |
-1.75% |
| 2023-12-31 | €47.64 Million ≈ $55.70 Million |
+93.25% |
| 2022-12-31 | €24.65 Million ≈ $28.82 Million |
-37.92% |
| 2021-12-31 | €39.71 Million ≈ $46.43 Million |
-- |
About INSPIREMD 1/18 DL-0001
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard c… Read more